May 8th 2024
Phase 2 data also highlight an improvement in disease control rate with setanaxib/pembrolizumab in squamous cell carcinoma of the head and neck.
Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Dialogues With the Surgeon on Integration of Systemic Therapies in Perioperative Settings for NSCLC: Looking at EGFR, ALK, IO, and Beyond…
View More
Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma
View More
Metformin Delays Progression of Thyroid Tumor Metastases in Mice
September 26th 2016Mitochondrial glycerophosphate dehydrogenase (mGPDH) is overexpressed in differentiated thyroid cancer (DTC) tissue, and metformin, which downregulates mGPDH, is associated with slowed growth in metastatic DTC tumors in mice.
Long-Term Data Validate Low-Dose I-131 for Low-Risk Thyroid Cancer
September 25th 2016Five years after treatment, low-dose postsurgical radioiodine (I-131) ablation for low-risk thyroid cancer offers outcomes equivalent to those seen following higher-dose ablation, according to a long-term follow-up analysis by French researchers.
Study Calls for Reclassification of Thyroid Tumors as Non-Cancerous
April 22nd 2016A new study is calling for a change in name for certain thyroid tumors. Patients diagnosed with what is currently known as noninvasive encapsulated follicular variant of papillary thyroid carcinoma have a very low risk for recurrence and therefore, researchers have suggested renaming the condition.
Pre-Op Ultrasound ID’s Important Prognostic Characteristics in Thyroid Cancer
March 18th 2016Researchers have identified several characteristics of metastatic papillary thyroid cancer shown on preoperative ultrasound-such as node matting-that are associated with extranodal extension, an important prognostic factor linked with this disease.
Physical Exams Adequate to Detect Thyroid Cancer in Cancer Survivors
February 3rd 2016The use of a standard yearly physical examination to screen for thyroid cancer among high-risk survivors of childhood and young adult cancers resulted in a negative predictive value of 100% for clinically relevant thyroid cancer and a significant cost savings compared with regular ultrasound screening.
Markers in Medullary Thyroid Cancer May Signal Metastasis, Vandetanib Response
October 22nd 2015Researchers in Germany appear to have identified a gene-expression signature associated with metastasis in sporadic medullary thyroid cancer and prognostic molecular tumor markers of medullary thyroid cancer response to vandetanib therapy.